Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PKN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP2B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM263 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDFIC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ND6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGFR1OP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHEK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF506 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NACA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAHD2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHMP4C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PREPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UGGT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GART - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBLCP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GMNN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLPP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on